Robert W. McMahon - 01 Mar 2026 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Signature
/s/ Caitlin Hippeli, as an agent for Robert W. McMahon
Issuer symbol
WST
Transactions as of
01 Mar 2026
Net transactions value
$0
Form type
4
Filing time
03 Mar 2026, 11:26:41 UTC
Previous filing
12 Feb 2026

Sponsored

Quoteable Key Fact

"Robert W. McMahon filed Form 4 for WEST PHARMACEUTICAL SERVICES INC (WST) on 03 Mar 2026."

Quick Takeaways

  • This page summarizes Robert W. McMahon's Form 4 filing for WEST PHARMACEUTICAL SERVICES INC (WST).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Filing timestamp: 03 Mar 2026, 11:26.

What Changed

  • Previous filing in this sequence was filed on 12 Feb 2026.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McMahon Robert W. SVP & Chief Financial Officer 530 HERMAN O. WEST DRIVE, EXTON /s/ Caitlin Hippeli, as an agent for Robert W. McMahon 03 Mar 2026 0001608730

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Rst. Stock Unit Award $0 +3,082 $0.000000 3,082 01 Mar 2026 Common Stock 3,082 Direct F1, F2
transaction WST Stock Option (Right to Buy) Award $0 +7,337 $0.000000 7,337 01 Mar 2026 Common Stock 7,337 $254.34 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of WST common stock.
F2 The restricted stock units vest in four equal annual installments beginning on March 1, 2027.
F3 The stock option vests in four equal annual installments beginning on March 1, 2027.